These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32628952)

  • 1. Regulatory B10 Cells Increase after Rituximab Therapy but Not after Conventional Immunosuppression in Patients with Pemphigus.
    Chen A; Yoshizaki A; Miyagaki T; Streilein RD; Tedder TF; Hall RP
    J Invest Dermatol; 2021 Feb; 141(2):443-446. PubMed ID: 32628952
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose rituximab and concurrent adjuvant therapy for pemphigus: Protocol and single-centre long-term review of nine patients.
    Robinson AJ; Vu M; Unglik GA; Varigos GA; Scardamaglia L
    Australas J Dermatol; 2018 Feb; 59(1):e47-e52. PubMed ID: 28211049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of B cells in immune-mediated dermatoses.
    Wang WM; Guo L; Jin HZ
    Mol Immunol; 2020 Oct; 126():95-100. PubMed ID: 32795664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased level of interleukin-10-producing B cells in patients with pemphigus but not in patients with pemphigoid.
    Kabuto M; Fujimoto N; Takahashi T; Tanaka T
    Br J Dermatol; 2017 May; 176(5):1204-1212. PubMed ID: 27716906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness and safety of rituximab in pemphigus vulgaris].
    Alonso Sánchez A; García Rodríguez S; López Avila A; Rabell Iñigo S
    Farm Hosp; 2010; 34(2):98-9. PubMed ID: 20304370
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of pemphigus].
    van Beek N; Zillikens D; Schmidt E
    Hautarzt; 2019 Apr; 70(4):243-253. PubMed ID: 30887081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients.
    Kasperkiewicz M; Shimanovich I; Meier M; Schumacher N; Westermann L; Kramer J; Zillikens D; Schmidt E
    Br J Dermatol; 2012 Jan; 166(1):154-60. PubMed ID: 21910700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low prevalence of late-onset neutropenia after rituximab treatment in patients with pemphigus.
    Boch K; Zillikens D; Langan EA; Schmidt E; Ludwig RJ
    J Am Acad Dermatol; 2020 Dec; 83(6):1824-1825. PubMed ID: 32450099
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Luger TA
    Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Remission maintenance with methotrexate, azathioprine or mycophenolate-mofetil after induction therapy with rituximab for granulomatosis with polyangiitis].
    Hellmich B
    Z Rheumatol; 2015 Mar; 74(2):157-8. PubMed ID: 25524229
    [No Abstract]   [Full Text] [Related]  

  • 11. Infective endocarditis due to Enterococcus faecalis manifesting as pemphigus foliaceus.
    Ioannou P; Tsagkaraki E; Vamvoukaki R; Kouvidou C; Krasagakis K; Chamilos G; Gikas A
    Hellenic J Cardiol; 2019; 60(3):202-204. PubMed ID: 30092274
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-desmoglein-1 levels as predictor of prednisolone tapering in pemphigus vulgaris patients treated with rituximab.
    Balighi K; Sakhi RS; Daneshpazhooh M; Mahmoudi H; Teimourpour A; Tavakolpour S
    Dermatol Ther; 2018 Nov; 31(6):e12671. PubMed ID: 30246907
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up.
    Cianchini G; Lupi F; Masini C; Corona R; Puddu P; De Pità O
    J Am Acad Dermatol; 2012 Oct; 67(4):617-22. PubMed ID: 22243765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of pemphigus.
    Tóth GG; Jonkman MF
    Clin Dermatol; 2001; 19(6):761-7. PubMed ID: 11705686
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppressive agents and bullous diseases].
    Beurey J; Weber M; Vadot J; Touret D
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):384-9. PubMed ID: 5510732
    [No Abstract]   [Full Text] [Related]  

  • 16. Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil.
    Biot Sdel R; Franco JP; Lima RB; Pereira HN; Marques LP; Martins CJ
    An Bras Dermatol; 2014; 89(6):980-4. PubMed ID: 25387507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged remission after immunosuppressive therapy in six dogs with pemphigus foliaceus.
    Olivry T; Bergvall KE; Atlee BA
    Vet Dermatol; 2004 Aug; 15(4):245-52. PubMed ID: 15305932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Unexpected positive outcome following rituximab treatment in a patient with pemphigus vegetans resistant to conventional therapies: a case report].
    Barbach Y; Baybay H; Mrabat S; Chaouche M; Elloudi S; Mernissi FZ
    Pan Afr Med J; 2019; 32():101. PubMed ID: 31223391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteric-coated mycophenolate sodium in the treatment of refractory pemphigus.
    Bongiorno MR; Pistone G; Doukaki S; Aricò M
    Int J Dermatol; 2010 Jun; 49(6):693-9. PubMed ID: 20618478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil as adjuvant in pemphigus vulgaris.
    Sarma N; Ghosh S
    Indian J Dermatol Venereol Leprol; 2007; 73(5):348-50. PubMed ID: 17921620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.